Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin

Key Points

• Elevated serum soluble ASGR1 concentration correlates with metabolic dysfunction associated with liver disease, indicating its potential as a biomarker.
• In obese patients, ASGR1 levels associated with increased adiponectin and insulin resistance, showing how metabolic factors interplay.
• Assessment of serum organokines among patients with steatosis provides insights into their role in liver inflammation and dysfunction.
• Understanding serum ASGR1 levels may lead to better strategies for managing metabolic liver disease; further analysis is needed.